[Medically assisted reproduction in couples carrying the human immunodeficiency virus].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 12371274)

Published in Bull Mem Acad R Med Belg on January 01, 2002

Authors

Y Englert1, B Lesage, I Place, C Kirkpatrick, M C Farber, F Devrecker, C Liesnard, J P Van Vooren

Author Affiliations

1: Clinique de fertilité, laboratoire de recherche en reproduction humaine, laboratoire de référence SIDA de l'U.L.B., Unité de traitement de l'immunodéficience humaine, Hôpital Erasme, Bruxelles.

Articles by these authors

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (1996) 15.91

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med (1996) 5.38

Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders. Ann Intern Med (1975) 3.36

Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand J Immunol (1988) 3.14

Armadillo is required for adherens junction assembly, cell polarity, and morphogenesis during Drosophila embryogenesis. J Cell Biol (1996) 2.89

Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG. Microb Pathog (1987) 2.66

Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice. Infect Immun (1992) 2.50

T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect Immun (1994) 2.18

Purification, partial characterization, and identification of a skin-reactive protein antigen of Mycobacterium bovis BCG. Infect Immun (1987) 2.12

Drosophila APC2 is a cytoskeletally-associated protein that regulates wingless signaling in the embryonic epidermis. J Cell Biol (1999) 2.04

[Medically assisted reproduction and the desire for a child by HIV infected couples: has the time for a change in attitude come?]]. Gynecol Obstet Fertil (2001) 2.03

Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation. J Virol (1997) 1.98

Genotypic and phenotypic methods for the investigation of a nosocomial Legionella pneumophila outbreak and efficacy of control measures. J Infect Dis (1992) 1.97

Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine (1997) 1.83

Humoral immune response in human tuberculosis: immunoglobulins G, A, and M directed against the purified P32 protein antigen of Mycobacterium bovis bacillus Calmette-Guérin. J Clin Microbiol (1988) 1.80

H-2-linked control of in vitro gamma interferon production in response to a 32-kilodalton antigen (P32) of Mycobacterium bovis bacillus Calmette-Guérin. Infect Immun (1988) 1.73

Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer. Infect Immun (2001) 1.50

Successful medical management of multifocal psoas abscess following cesarean section: report of a case and review of the literature. Eur J Obstet Gynecol Reprod Biol (2002) 1.48

Early- and late-stage Kaposi's sarcoma lesions exhibit similar proliferation fraction. Am J Dermatopathol (1999) 1.40

[Screening strategy and diagnostic criteria for gestational diabetes. Proposals of the GGOLFB]. Rev Med Brux (2012) 1.40

Rapid detection of tuberculous and non-tuberculous mycobacteria by polymerase chain reaction amplification of a 162 bp DNA fragment from antigen 85. Eur J Clin Microbiol Infect Dis (1992) 1.38

Classic Kaposi's sarcoma after multiple-partner heterosexual behavior in Central Africa. J Am Acad Dermatol (1999) 1.38

Drosophila alpha-catenin and E-cadherin bind to distinct regions of Drosophila Armadillo. J Biol Chem (1996) 1.36

Roles of the C terminus of Armadillo in Wingless signaling in Drosophila. Genetics (1999) 1.32

Constitutive release of metalloproteinase-9 (92-kd type IV collagenase) by Kaposi's sarcoma cells. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.21

Sacral nerve stimulation in patients with chronic intractable pelvic pain. J Urol (2001) 1.21

Pitfalls of using estimations of glomerular filtration rate in an intensive care population. Intern Med J (2011) 1.21

Repertoires of antibodies to culture filtrate antigens in different mouse strains infected with Mycobacterium bovis BCG. Infect Immun (1990) 1.21

Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor. Curr Biol (1999) 1.19

Effect of zinc deficiency on the appearance of two immunodominant protein antigens (32 kDa and 65 kDa) in culture filtrates of mycobacteria. J Gen Microbiol (1989) 1.15

Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy. J Urol (1999) 1.15

Accuracy of amniotic fluid testing before 21 weeks' gestation in prenatal diagnosis of congenital cytomegalovirus infection. Prenat Diagn (1994) 1.14

Cadherin sequences that inhibit beta-catenin signaling: a study in yeast and mammalian cells. Mol Biol Cell (2001) 1.13

Fatal varicella in an immunocompromised adult. Dermatology (1993) 1.11

Biological response of endothelial cells and its modulation by cytokines: prospects for therapy and bioprocesses. Cytotechnology (1997) 1.10

Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus. Eur J Clin Microbiol Infect Dis (1995) 1.09

Species-specific Mycobacterium genavense DNA in intestinal tissues of individuals not infected with human immunodeficiency virus. J Clin Microbiol (1995) 1.09

Fibronectin-binding antigen 85 and the 10-kilodalton GroES-related heat shock protein are the predominant TH-1 response inducers in leprosy contacts. Infect Immun (1995) 1.08

Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis. Br Med J (Clin Res Ed) (1986) 1.07

Comparison of the immunogenicity and safety of two 17D yellow fever vaccines. Am J Trop Med Hyg (1999) 1.05

Value of standard laboratory tests for the early recognition of group A beta-hemolytic streptococcal necrotizing fasciitis. Clin Infect Dis (2001) 1.05

An isoelectric focusing method for the study of the humoral response against the antigen 85 complex of Mycobacterium bovis BCG in the different forms of leprosy. J Immunol Methods (1991) 1.03

Influence of genes from the major histocompatibility complex on the antibody repertoire against culture filtrate antigens in mice infected with live Mycobacterium bovis BCG. Infect Immun (1993) 1.01

HIV-1 infectivity and host range modification by cathepsin D present in human vaginal secretions. AIDS (1999) 1.00

Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group. Scand J Immunol (1997) 0.99

The major secreted antigen complex (Ag 85) from Mycobacterium bovis bacille Calmette-Guérin is associated with protective T cells in leprosy: a follow-up study of 45 household contacts. J Infect Dis (1993) 0.99

Pyogenic arthritis caused by streptococcus equisimilis (group-C streptococcus) in a patient with AIDS. Clin Rheumatol (1997) 0.97

Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature. Transplantation (1998) 0.97

Holt Oram syndrome mistaken for thalidomide embryopathy--embryological considerations. Eur J Pediatr (1982) 0.96

Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models. Gene Ther (2010) 0.96

Prenatal diagnosis of 52 pregnancies at risk for congenital cytomegalovirus infection. Obstet Gynecol (1993) 0.96

Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assay. J Clin Microbiol (2010) 0.96

Isoelectrophoretic characterization of protein antigens present in mycobacterial culture filtrates and recognized by monoclonal antibodies directed against the Mycobacterium bovis BCG antigen 85 complex. Scand J Immunol (1992) 0.96

What are the immunologically active components of bacille Calmette-Guérin in therapy of superficial bladder cancer? Int J Cancer (2000) 0.95

Circulating thymic-hormone activity in congenital immunodeficiency. Lancet (1977) 0.95

Antibody levels to whole culture filtrate antigens and to purified P32 during treatment of smear-positive tuberculosis. Chest (1991) 0.95

Phenotypic characteristics of Kaposi's sarcoma tumour cells derived from patch-, plaque- and nodular-stage lesions: analysis of cell cultures isolated from AIDS and non-AIDS patients and review of the literature. Br J Dermatol (2000) 0.94

No Mycobacterium paratuberculosis found in Crohn's disease using polymerase chain reaction. Dig Dis Sci (1996) 0.94

The immune status of healthy centenarians. J Am Geriatr Soc (1984) 0.94

pH-dependent protein profiles of Helicobacter pylori analyzed by two-dimensional gels. Helicobacter (2000) 0.93

Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors. J Invest Dermatol (2000) 0.92

[Hereditary ornithine-carbamyl-transferase deficiency with qualitative enzyme abnormality. Report of a form with neonatal revelation and fatal course in a boy]. Arch Fr Pediatr (1973) 0.92

Materno-fetal immunoglobulin transfer and passive immunity during the first trimester of human pregnancy. Hum Reprod (1995) 0.92

Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guérin (BCG) in patients with superficial bladder cancer. Clin Exp Immunol (1997) 0.92

ART in HIV-infected couples: has the time come for a change of attitude? Hum Reprod (2001) 0.91

T-cell stimulation with purified mycobacterial antigens in patients and healthy subjects infected with Mycobacterium leprae: secreted antigen 85 is another immunodominant antigen. Scand J Immunol (1993) 0.91

Comparison of pregnancy outcome after intracytoplasmic sperm injection and in-vitro fertilization. Hum Reprod (1998) 0.90

Role of bronchoalveolar lavage in diagnosis of disseminated toxoplasmosis. Rev Infect Dis (1991) 0.89

Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clinical trial. Arzneimittelforschung (1996) 0.89

A human milk factor susceptible to cathepsin D inhibitors enhances human immunodeficiency virus type 1 infectivity and allows virus entry into a mammary epithelial cell line. J Virol (2000) 0.88

A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH). Nutr Metab Cardiovasc Dis (2000) 0.88

Importance of method in the determination of syncytium-inducing phenotype of human immunodeficiency virus type 1 clinical isolates. J Virol Methods (1997) 0.87

Rapid simple and nested polymerase chain reaction for the diagnosis of Pneumocystis carinii pneumonia. Scand J Infect Dis (1995) 0.86

Bovine and human endothelial cell growth on collagen microspheres and their infection with the rickettsia Cowdria ruminantium: prospects for cells and vaccine production. Rev Elev Med Vet Pays Trop (1993) 0.86

Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer. J Urol (1997) 0.85

Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals. Vaccine (2001) 0.85

Disposition of liposomal gentamicin following intrabronchial administration in rabbits. J Microencapsul (1993) 0.85

T cell reactivity against antigen 85 but not against the 18- and 65-kD heat shock proteins in the early stages of acquired immunity against Mycobacterium leprae. Clin Exp Immunol (1994) 0.85

Detection of fastidious mycobacteria in human intestines by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis (1997) 0.84

Kaposi's sarcoma and herpesvirus 8: a word of caution. Dermatology (1996) 0.84

Tuberculous inguinal and crural lymph nodes. Dermatology (1998) 0.83

Anonymity and secrecy options of recipient couples and donors, and ethnic origin influence in three types of oocyte donation. Hum Reprod (2010) 0.83

Iron as a potential co-factor in the pathogenesis of Kaposi's sarcoma? Int J Cancer (1998) 0.83

p53 protein overexpression is a common but late event in the pathogenesis of iatrogenic and AIDS-related Kaposi's sarcoma. Arch Dermatol Res (1997) 0.83

Fatal primary infection due to human herpesvirus 6 variant A in a renal transplant recipient. Transplantation (2001) 0.82

Listeria monocytogenes hepatitis in a liver transplant recipient: a case report and review of the literature. J Hepatol (1993) 0.82

Immunological detection of mycobacterial antigens in infected fluids, cells and tissues by latex agglutination. Animal model and clinical application. J Immunol Methods (1990) 0.82

Selective feticide by embolization in twin-twin transfusion syndrome. A report of two cases. J Reprod Med (1997) 0.82

Management of the growth-restricted fetus: the role of noninvasive tests and fetal blood sampling. Obstet Gynecol (1995) 0.82

Assessing utility of single photon emission computed tomography (SPECT) scan in Alzheimer disease: correlation with cognitive severity. Alzheimer Dis Assoc Disord (1990) 0.82

[Screening strategy and diagnostic criteria for gestational diabetes. Proposals of the GGOLFB]. Rev Med Liege (2012) 0.82